1 Min Read
Oct 7 (Reuters) - Medrx Co Ltd :
* Says it commenced the phase I clinical trial for spastic paralysis treatment plasters(MRX-4TZT) in the U.S.
Source text in Japanese:goo.gl/N7uk4m
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.